Laboratory for Organic & Microwave-Assisted Chemistry (LOMAC), Department of Chemistry, Katholieke Universiteit Leuven, Celestijnenlaan 200F, B-3001, Leuven, Belgium; DestiNA Genomics Ltd, West Mains Road, Edinburgh, EH9 3JJ, UK.
J Pept Sci. 2013 Oct;19(10):651-8. doi: 10.1002/psc.2543. Epub 2013 Aug 27.
The integration of the viral DNA into the host genome is one of the essential steps in the HIV replication cycle. This process is mediated by the viral enzyme integrase (IN) and lens epithelium-derived growth factor (LEDGF/p75). LEDGF/p75 has been identified as a crucial cellular co-factor of integration that acts by tethering IN to the cellular chromatin. Recently, circular peptides were identified that bind to the C-terminal domain of IN and disrupt the interaction with LEDGF/p75. Starting from the circular peptides, we identified a short peptidic sequence able to inhibit the LEDGF/p75-IN interaction at low μM concentration through its binding to the IN binding site of LEDGF/p75. This discovery can lead to the synthesis of peptidomimetics with high anti-HIV activity targeting the cellular co-factor LEDGF/p75 and not the viral protein IN.
病毒 DNA 整合到宿主基因组是 HIV 复制周期中的关键步骤之一。这个过程是由病毒酶整合酶(IN)和晶状体上皮衍生生长因子(LEDGF/p75)介导的。LEDGF/p75 已被确定为整合的关键细胞辅助因子,通过将 IN 固定在细胞染色质上来发挥作用。最近,已经鉴定出与 IN 的 C 端结构域结合并破坏与 LEDGF/p75 相互作用的环状肽。从环状肽出发,我们鉴定出一个短的肽序列,能够通过与 LEDGF/p75 的 IN 结合位点结合,以低 μM 浓度抑制 LEDGF/p75-IN 相互作用。这一发现可以导致合成具有高抗 HIV 活性的肽模拟物,针对细胞辅助因子 LEDGF/p75,而不是病毒蛋白 IN。